Table 4. Independent predictors of chemotherapy induced left ventricular dysfunction.

Variable	RR	CI	p-value
Low BMI	2.207	1.247–3.928	0.007
Triglyceride	0.995	0.990–1.001	0.109
Advanced cancer stage	1.782	1.067–2.974	0.027
LVEDD	1.121	1.006–1.248	0.138
LVEF	1.120	0.862–1.454	0.398
Chemotherapy cycle	0.959	0.873–1.053	0.382
Doxorubicin therapy	1.363	0.745–2.493	0.315
Paclitaxel therapy	0.991	0.558–1.762	0.975
Trastuzumab therapy	5.080	2.998–8.609	< 0.001
Radiation therapy	1.436	1.182–1.880	0.086

RR=relative risk; CI=confidence interval; BMI=body mass index; LVEDD=left ventricle end diastolic dimension; LVEF=left ventricular ejection fraction.